TC
IRWD icon

Truvestments Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Truvestments Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71K Buy
+643
New +$2.48K ﹤0.01% 991

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Truvestments Capital's IRWD Position: Q2 2026 in Review

Truvestments Capital opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 643 shares worth $2.71K. The stake represents ﹤0.01% of the portfolio and ranks #991 among its holdings.

212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Truvestments Capital held 643 shares of Ironwood Pharmaceuticals worth $2.71K as of Q2 2026.
  • Ironwood Pharmaceuticals was a new Truvestments Capital position in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #991 holding.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.